Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   

The Angels Initiative

Stroke prevention

  Liver Diseases

  Free Subscription

Articles published in Dig Dis Sci

Retrieve available abstracts of 230 articles:
HTML format

Single Articles

    June 2022
  1. OHNO A, Fujimori N, Kaku T, Takamatsu Y, et al
    Feasibility and Efficacy of Endoscopic Ultrasound-Guided Hepaticogastrostomy Without Dilation: A Propensity Score Matching Analysis.
    Dig Dis Sci. 2022 Jun 10. pii: 10.1007/s10620-022-07555.
    PubMed     Abstract available

  2. DHIR V, Bale A
    EUS-Guided Hepatico-Gastrostomy: To Dilate or Not to Dilate?
    Dig Dis Sci. 2022 Jun 10. pii: 10.1007/s10620-022-07560.

  3. KUGELMAS M, Zapata I, Tawil J, Pessetto A, et al
    Liver Cirrhosis Increases the Risk of Developing Advanced Colon Polyps.
    Dig Dis Sci. 2022 Jun 7. pii: 10.1007/s10620-022-07561.
    PubMed     Abstract available

  4. PAN AY, Zilberstein NF, Farnan JM, McConville JF, et al
    Recently Graduated Medical Students Lack Exposure to and Comfort with Chronic Liver Diseases.
    Dig Dis Sci. 2022;67:2081-2085.
    PubMed     Abstract available

  5. TESTINO G, Vignoli T, Patussi V, Allosio P, et al
    Alcohol-Related Liver Disease in the Covid-19 Era: Position Paper of the Italian Society on Alcohol (SIA).
    Dig Dis Sci. 2022;67:1975-1986.
    PubMed     Abstract available

  6. GLASS L, Asefa H, Volk M, Lok AS, et al
    Disease Knowledge, Health-Related Quality of Life, and Lifestyle Behavior Change in Patients with Nonalcoholic Fatty Liver Disease: Impact of an Educational Intervention.
    Dig Dis Sci. 2022;67:2123-2133.
    PubMed     Abstract available

  7. NABI O, Boursier J, Lacombe K, Mathurin P, et al
    Comorbidities Are Associated with Fibrosis in NAFLD Subjects: A Nationwide Study (NASH-CO Study).
    Dig Dis Sci. 2022;67:2584-2593.
    PubMed     Abstract available

  8. SIDDIQUI MA, Suresh S, Simmer S, Abu-Ghanimeh M, et al
    Increased Morbidity and Mortality in COVID-19 Patients with Liver Injury.
    Dig Dis Sci. 2022;67:2577-2583.
    PubMed     Abstract available

    May 2022
  9. ASOTIBE JC, Banini BA
    Hepatic Hydrothorax: An Independent Predictor of Mortality in Cirrhosis? Is the MELD-Na Score Worth Its Salt?
    Dig Dis Sci. 2022 May 9. pii: 10.1007/s10620-022-07523.

  10. OSMAN KT, Abdelfattah AM, Mahmood SK, Elkhabiry L, et al
    Refractory Hepatic Hydrothorax Is an Independent Predictor of Mortality When Compared to Refractory Ascites.
    Dig Dis Sci. 2022 May 9. pii: 10.1007/s10620-022-07522.
    PubMed     Abstract available

  11. AL-OBAID LN, Bazarbashi AN, Ryou M
    Variceal Bleeding: Beyond Banding.
    Dig Dis Sci. 2022;67:1442-1454.
    PubMed     Abstract available

    April 2022
  12. B HADI Y, Khan RS, Lakhani DA, Khan AY, et al
    Antibiotic Prophylaxis for Upper Gastrointestinal Bleed in Liver Cirrhosis; Less May Be More.
    Dig Dis Sci. 2022 Apr 25. pii: 10.1007/s10620-022-07481.
    PubMed     Abstract available

  13. ZHAO M, Ma L, Honda T, Kato A, et al
    Astaxanthin Attenuates Nonalcoholic Steatohepatitis with Downregulation of Osteoprotegerin in Ovariectomized Mice Fed Choline-Deficient High-Fat Diet.
    Dig Dis Sci. 2022 Apr 10. pii: 10.1007/s10620-022-07489.
    PubMed     Abstract available

  14. NOBARANI S, Alaei-Shahmiri F, Aghili R, Malek M, et al
    Visceral Adipose Tissue and Non-alcoholic Fatty Liver Disease in Patients with Type 2 Diabetes.
    Dig Dis Sci. 2022;67:1389-1398.
    PubMed     Abstract available

  15. NOUREDDIN N, Noureddin M, Singh A, Alkhouri N, et al
    Progression of Nonalcoholic Fatty Liver Disease-Associated Fibrosis in a Large Cohort of Patients with Type 2 Diabetes.
    Dig Dis Sci. 2022;67:1379-1388.
    PubMed     Abstract available

    March 2022
  16. TAKIGAWA A, Sakamori R, Tahata Y, Yoshioka T, et al
    Prediction Model for Intrahepatic Distant Recurrence After Radiofrequency Ablation for Primary Hepatocellular Carcinoma 2 cm or Smaller.
    Dig Dis Sci. 2022 Mar 30. pii: 10.1007/s10620-022-07455.
    PubMed     Abstract available

  17. BUCSICS T, Lampichler K, Vierziger C, Schoder M, et al
    Covered Transjugular Intrahepatic Portosystemic Shunt Improves Hypersplenism-Associated Cytopenia in Cirrhosis.
    Dig Dis Sci. 2022 Mar 17. pii: 10.1007/s10620-022-07443.
    PubMed     Abstract available

  18. RAMANI A, Tapper EB, Griffin C, Shankar N, et al
    Hepatocellular Carcinoma-Related Mortality in the USA, 1999-2018.
    Dig Dis Sci. 2022 Mar 14. pii: 10.1007/s10620-022-07433.
    PubMed     Abstract available

  19. CHOI AY, Chang KJ, Samarasena JB, Lee JG, et al
    Endoscopic Ultrasound-Guided Porto-systemic Pressure Gradient Measurement Correlates with Histological Hepatic Fibrosis.
    Dig Dis Sci. 2022 Mar 12. pii: 10.1007/s10620-022-07418.
    PubMed     Abstract available

  20. LEE TH, Hirshman N, Cardona DM, Berg CL, et al
    LR-3 and LR-4 Lesions Are More Likely to Be Hepatocellular Carcinoma in Transplant Patients with LR-5 or LR-TR Lesions.
    Dig Dis Sci. 2022 Mar 7. pii: 10.1007/s10620-022-07428.
    PubMed     Abstract available

  21. ZHAO Z, Gao J, Huang S
    LncRNA SNHG7 Promotes the HCC Progression Through miR-122-5p/FOXK2 Axis.
    Dig Dis Sci. 2022;67:925-935.
    PubMed     Abstract available

  22. BHURWAL A, Makar M, Patel A, Mutneja H, et al
    Safety and Efficacy of Thrombin for Bleeding Gastric Varices: A Systematic Review and Meta-Analysis.
    Dig Dis Sci. 2022;67:953-963.
    PubMed     Abstract available

    February 2022
  23. DIBATTISTA JV, Burkholder DA, Lok AS, Chen VL, et al
    Accuracy of Non-invasive Indices for Diagnosing Hepatic Steatosis Compared to Imaging in a Real-World Cohort.
    Dig Dis Sci. 2022 Feb 15. pii: 10.1007/s10620-022-07415.
    PubMed     Abstract available

  24. SINGH AD, Ford A, Lyu R, Layoun H, et al
    Impact of Cirrhotic Cardiomyopathy Diagnosed According to Different Criteria on Patients with Cirrhosis Awaiting Liver Transplantation: A Retrospective Cohort Study.
    Dig Dis Sci. 2022 Feb 12. pii: 10.1007/s10620-022-07412.
    PubMed     Abstract available

  25. ROGAL SS, Chinman MJ, DeMonte W, Gibson S, et al
    Using Intervention Mapping to Develop a Novel Pain Self-Management Intervention for People with Cirrhosis.
    Dig Dis Sci. 2022 Feb 11. pii: 10.1007/s10620-022-07380.
    PubMed     Abstract available

  26. SHENOY A, Louissaint J, Shannon C, Tapper EB, et al
    Viscoelastic Testing Prior to Non-surgical Procedures Reduces Blood Product Use Without Increasing Bleeding Risk in Cirrhosis.
    Dig Dis Sci. 2022 Feb 5. pii: 10.1007/s10620-021-07376.
    PubMed     Abstract available

  27. JINDAL A, Sarin SK, Kumar M, Kumar G, et al
    Clinical Outcomes in Patients with Advanced Chronic Liver Disease and Hepatic Venous Pressure Gradient
    Dig Dis Sci. 2022 Feb 3. pii: 10.1007/s10620-021-07334.
    PubMed     Abstract available

  28. GIBBS JT, Louissaint J, Tapper EB
    Rate of Successful Extubation in Mechanically Ventilated Patients with Cirrhosis and Hepatic Coma.
    Dig Dis Sci. 2022 Feb 2. pii: 10.1007/s10620-022-07400.
    PubMed     Abstract available

  29. FAUST A, Stine JG
    Time to Step It Up: Mobile Health Intervention for Lifestyle Modification in Patients with Nonalcoholic Fatty Liver Disease.
    Dig Dis Sci. 2022;67:403-405.

  30. CHAUHAN M, Singh K, Thuluvath PJ
    Bariatric Surgery in NAFLD.
    Dig Dis Sci. 2022;67:408-422.
    PubMed     Abstract available

  31. TINCOPA MA, Lyden A, Wong J, Jackson EA, et al
    Impact of a Pilot Structured Mobile Technology Based Lifestyle Intervention for Patients with Nonalcoholic Fatty Liver Disease.
    Dig Dis Sci. 2022;67:481-491.
    PubMed     Abstract available

  32. LI Y, Chen C, Lu L, Guo W, et al
    Cadmium Exposure in Young Adulthood Is Associated with Risk of Nonalcoholic Fatty Liver Disease in Midlife.
    Dig Dis Sci. 2022;67:689-696.
    PubMed     Abstract available

    January 2022
  33. GONZALEZ JJ, Dziwis J, Patel YA, Tapper EB, et al
    Identifying Ascites in Patients with Cirrhosis Using Administrative Codes and Diuretic Use: A Multicenter Study.
    Dig Dis Sci. 2022 Jan 28. pii: 10.1007/s10620-021-07367.
    PubMed     Abstract available

  34. PARK MK, Lee YB, Moon H, Choi NR, et al
    Effectiveness of Lenvatinib Versus Sorafenib for Unresectable Hepatocellular Carcinoma in Patients with Hepatic Decompensation.
    Dig Dis Sci. 2022 Jan 20. pii: 10.1007/s10620-021-07365.
    PubMed     Abstract available

  35. PANCHAL SA, Kaplan DE, Goldberg DS, Mahmud N, et al
    Algorithms to Identify Alcoholic Hepatitis Hospitalizations in Patients with Cirrhosis.
    Dig Dis Sci. 2022 Jan 13. pii: 10.1007/s10620-021-07321.
    PubMed     Abstract available

  36. CHANDAN S, Deliwala S, Khan SR, Ramai D, et al
    Advanced Endoscopic Resection Techniques in Cirrhosis-A Systematic Review and Meta-Analysis of Outcomes.
    Dig Dis Sci. 2022 Jan 6. pii: 10.1007/s10620-021-07364.
    PubMed     Abstract available

  37. WEGERMANN K, Wilder JM, Parish A, Niedzwiecki D, et al
    Racial and Socioeconomic Disparities in Utilization of Telehealth in Patients with Liver Disease During COVID-19.
    Dig Dis Sci. 2022;67:93-99.
    PubMed     Abstract available

  38. WAHID N, Rosenblatt R
    Disparities in Telehealth for Liver Disease: Revealing What Was Hidden in Plain Sight.
    Dig Dis Sci. 2022;67:3-5.

  39. NAJAFIAN N, Weber AT, Zuckerman JE, Zhang S, et al
    AL Lambda Amyloidosis Activates Acute Liver Failure in the Absence of Plasma Cell Dyscrasia.
    Dig Dis Sci. 2022;67:67-70.
    PubMed     Abstract available

  40. KHALIFA A, Sasso R, Rockey DC
    Role of Liver Biopsy in Assessment of Radiologically Identified Liver Masses.
    Dig Dis Sci. 2022;67:337-343.
    PubMed     Abstract available

  41. WANGRATTANAPRANEE P, Khrucharoen U, Jensen DM, Wongpongsalee T, et al
    Severe Upper Gastrointestinal Hemorrhage Caused by Reflux Esophagitis.
    Dig Dis Sci. 2022;67:159-169.
    PubMed     Abstract available

    December 2021
  42. JOHNSON KD, Perisetti A, Goyal H, Thandassery R, et al
    Liver Biopsy in Pregnancy: Two Case Reports and Review of the Literature.
    Dig Dis Sci. 2021;66:4090-4098.
    PubMed     Abstract available

  43. YAN Y, Xing X, Wang X, Men R, et al
    Development and Validation of an Easy-to-Use Risk Scoring System for Screening High-Risk Varices in Patients with HBV-Related Compensated Advanced Chronic Liver Disease.
    Dig Dis Sci. 2021;66:4518-4524.
    PubMed     Abstract available

  44. HIGUERA-DE-LA-TIJERA F, Cordova-Gallardo J, Buganza-Torio E, Barranco-Fragoso B, et al
    Hepamet Fibrosis Score in Nonalcoholic Fatty Liver Disease Patients in Mexico: Lower than Expected Positive Predictive Value.
    Dig Dis Sci. 2021;66:4501-4507.
    PubMed     Abstract available

  45. DHALIWAL HS, Singh R, Abraham AM, Sharma R, et al
    Perception of Illness and Its Association with Treatment Willingness in Patients with Newly Diagnosed Nonalcoholic Fatty Liver Disease.
    Dig Dis Sci. 2021;66:4197-4207.
    PubMed     Abstract available

    November 2021
  46. CHANG JI, Sinn DH, Cho H, Kim S, et al
    Clinical Outcomes of Hepatitis B Virus-Related Hepatocellular Carcinoma Patients with Undetectable Serum HBV DNA Levels.
    Dig Dis Sci. 2021 Nov 20. pii: 10.1007/s10620-021-07312.
    PubMed     Abstract available

  47. DONG TS, Jacobs JP, Agopian V, Pisegna JR, et al
    Duodenal Microbiome and Serum Metabolites Predict Hepatocellular Carcinoma in a Multicenter Cohort of Patients with Cirrhosis.
    Dig Dis Sci. 2021 Nov 20. pii: 10.1007/s10620-021-07299.
    PubMed     Abstract available

  48. PODRUG K, Trkulja V, Zelenika M, Bokun T, et al
    Validation of the New Diagnostic Criteria for Clinically Significant Portal Hypertension by Platelets and Elastography.
    Dig Dis Sci. 2021 Nov 5. pii: 10.1007/s10620-021-07277.
    PubMed     Abstract available

    Pressure Measurements Under Pressure: Simplifying the Diagnosis of Clinically Significant Portal Hypertension.
    Dig Dis Sci. 2021 Nov 5. pii: 10.1007/s10620-021-07283.

  50. MANKA PP, Kaya E, Canbay A, Syn WK, et al
    A Review of the Epidemiology, Pathophysiology, and Efficacy of Anti-diabetic Drugs Used in the Treatment of Nonalcoholic Fatty Liver Disease.
    Dig Dis Sci. 2021;66:3676-3688.
    PubMed     Abstract available

  51. KOSICK HM, Keyrouz A, Adeyi O, Sebastiani G, et al
    A Stepwise Algorithmic Approach and External Validation Study for Noninvasive Prediction of Advanced Fibrosis in Nonalcoholic Fatty Liver Disease.
    Dig Dis Sci. 2021;66:4046-4057.
    PubMed     Abstract available

  52. ABDU B, Akolkar S, Picking C, Boura J, et al
    Factors Associated with Delayed Paracentesis in Patients with Spontaneous Bacterial Peritonitis.
    Dig Dis Sci. 2021;66:4035-4045.
    PubMed     Abstract available

    October 2021
  53. BURKHOLDER DA, Moran IJ, DiBattista JV, Lok AS, et al
    Accuracy of International Classification of Diseases-10 Codes for Cirrhosis and Portal Hypertensive Complications.
    Dig Dis Sci. 2021 Oct 21. pii: 10.1007/s10620-021-07282.
    PubMed     Abstract available

  54. LI W, Xue H, Li Y, Li P, et al
    HIPK3 Circular RNA Promotes Metastases of HCC Through Sponging miR-338-3p to Induce ZEB2 Expression.
    Dig Dis Sci. 2021;66:3439-3447.
    PubMed     Abstract available

  55. STINE JG, Soriano C, Schreibman I, Rivas G, et al
    Breaking Down Barriers to Physical Activity in Patients with Nonalcoholic Fatty Liver Disease.
    Dig Dis Sci. 2021;66:3604-3611.
    PubMed     Abstract available

    September 2021
  56. KONG J, Liang X, Zhang J, Zeng J, et al
    Antiviral Therapy Improves Survival in Hepatocellular Carcinoma with Microvascular Invasion: A Propensity Score Analysis.
    Dig Dis Sci. 2021 Sep 14. pii: 10.1007/s10620-021-07248.
    PubMed     Abstract available

  57. JEON Y, Limketkai BN
    Arrested Development: Slow Progression of Fibrosis in Patients with NAFLD and IBD.
    Dig Dis Sci. 2021;66:2853-2854.

  58. LABENZ C, Kostev K, Kaps L, Galle PR, et al
    Incident Dementia in Elderly Patients with Nonalcoholic Fatty Liver Disease in Germany.
    Dig Dis Sci. 2021;66:3179-3185.
    PubMed     Abstract available

  59. UFERE NN, Donlan J, Indriolo T, Richter J, et al
    Burdensome Transitions of Care for Patients with End-Stage Liver Disease and Their Caregivers.
    Dig Dis Sci. 2021;66:2942-2955.
    PubMed     Abstract available

    August 2021
  60. YOPES MC, Mozeika AM, Liebling S, Haslam A, et al
    An Analysis of 5 Years of Randomized Trials in Gastroenterology and Hepatology Reveals 52 Medical Reversals.
    Dig Dis Sci. 2021 Aug 31. pii: 10.1007/s10620-021-07199.
    PubMed     Abstract available

  61. HANSEN L, Chang MF, Hiatt S, Dieckmann NF, et al
    Symptom Frequency and Distress Underestimated in Decompensated Cirrhosis.
    Dig Dis Sci. 2021 Aug 27. pii: 10.1007/s10620-021-07216.
    PubMed     Abstract available

  62. LOUISSAINT J, Kassab I, Yeboah-Korang A, Fontana RJ, et al
    Combining K-72 Hepatic Failure with 15 Individual T-Codes to Identify Patients with Idiosyncratic Drug-Induced Liver Injury in the Electronic Medical Record.
    Dig Dis Sci. 2021 Aug 24. pii: 10.1007/s10620-021-07223.
    PubMed     Abstract available

  63. TRIVEDI HD, Niezen S, Jiang ZG, Tapper EB, et al
    Severe Hepatic Steatosis by Controlled Attenuation Parameter Predicts Quality of Life Independent of Fibrosis.
    Dig Dis Sci. 2021 Aug 21. pii: 10.1007/s10620-021-07228.
    PubMed     Abstract available

  64. VIJAYARAGHAVAN R, Maiwall R, Arora V, Choudhary A, et al
    Reversal of Feed Intolerance by Prokinetics Improves Survival in Critically Ill Cirrhosis Patients.
    Dig Dis Sci. 2021 Aug 14. pii: 10.1007/s10620-021-07185.
    PubMed     Abstract available

  65. CHEN Y, Li H, Chen D, Jiang X, et al
    Hypoxic Hepatocellular Carcinoma Cells Acquire Arsenic Trioxide Resistance by Upregulating HIF-1alpha Expression.
    Dig Dis Sci. 2021 Aug 12. pii: 10.1007/s10620-021-07202.
    PubMed     Abstract available

  66. THAKER S, Mikolajczyk AE
    Concise Commentary: Are We Making a Difference? The Impact of Inpatient Gastroenterology and Hepatology Consultations for Cirrhotic Patients.
    Dig Dis Sci. 2021 Aug 10. pii: 10.1007/s10620-021-07171.

  67. SERPER M, Kaplan DE, Lin M, Taddei TH, et al
    Inpatient Gastroenterology Consultation and Outcomes of Cirrhosis-Related Hospitalizations in Two Large National Cohorts.
    Dig Dis Sci. 2021 Aug 10. pii: 10.1007/s10620-021-07150.
    PubMed     Abstract available

  68. OH JH, Goh MJ, Park Y, Kim J, et al
    Different Performance of Liver Stiffness Measurement According to Etiology and Outcome for the Prediction of Liver-Related Events.
    Dig Dis Sci. 2021;66:2816-2825.
    PubMed     Abstract available

  69. NOZAWA H, Emoto S, Sonoda H, Kawai K, et al
    Liver Injury Among Japanese Patients Treated Using Prophylactic Enoxaparin After Colorectal Surgery.
    Dig Dis Sci. 2021;66:2805-2815.
    PubMed     Abstract available

    July 2021
  70. BOCKORNY B, Bullock AJ, Abrams TA, Faintuch S, et al
    Priming of Sorafenib Prior to Radiofrequency Ablation Does Not Increase Treatment Effect in Hepatocellular Carcinoma.
    Dig Dis Sci. 2021 Jul 23. pii: 10.1007/s10620-021-07156.
    PubMed     Abstract available

  71. CULLARO G, Rubin JB, Fortune BE, Crawford CV, et al
    Association Between Kidney Dysfunction Types and Mortality Among Hospitalized Patients with Cirrhosis.
    Dig Dis Sci. 2021 Jul 22. pii: 10.1007/s10620-021-07159.
    PubMed     Abstract available

  72. HAI Y, Chong W, Eisenbrey JR, Forsberg F, et al
    Network Meta-Analysis: Noninvasive Imaging Modalities for Identifying Clinically Significant Portal Hypertension.
    Dig Dis Sci. 2021 Jul 17. pii: 10.1007/s10620-021-07168.
    PubMed     Abstract available

  73. BARNES EL, Grimm-Vavlitis JL, Long MD
    Impact of Virtual Interviews on Gastroenterology and Hepatology Fellowship Recruitment.
    Dig Dis Sci. 2021 Jul 15. pii: 10.1007/s10620-021-07123.

  74. LIU J, He X, Zou Y, Wang K, et al
    Circular RNA Circ-STIL Contributes to Cell Growth and Metastasis in Hepatocellular Carcinoma via Regulating miR-345-5p/AQP3 Axis.
    Dig Dis Sci. 2021 Jul 6. pii: 10.1007/s10620-021-07054.
    PubMed     Abstract available

  75. MANKA P, Syn WK
    NASH, Metabolic Syndrome, and Diabetes: How Sugar and Fat Increase the Risk of Developing Advanced Liver Disease.
    Dig Dis Sci. 2021;66:2147-2148.

  76. BOPPANA V, Sahni S, Glass J, Chang C, et al
    HCC You Cannot See.
    Dig Dis Sci. 2021;66:2185-2189.

  77. MARTIN M, Zou B, Hoang J, Jeong D, et al
    Racial and Socioeconomic Disparities in Hospitalization of Pediatrics with Liver Disease from 2005 to 2015.
    Dig Dis Sci. 2021;66:2240-2249.
    PubMed     Abstract available

    June 2021
  78. DELEURAN T, Watson H, Vilstrup H, Jepsen P, et al
    Risk Factors for Hepatic Hydrothorax in Cirrhosis Patients with Ascites - A Clinical Cohort Study.
    Dig Dis Sci. 2021 Jun 30. pii: 10.1007/s10620-021-07134.
    PubMed     Abstract available

  79. ZHOU K, Dodge JL, Yuan L, Terrault NA, et al
    Metabolic Risk Profiles for Hepatic Steatosis Differ by Race/Ethnicity: An Elastography-Based Study of US Adults.
    Dig Dis Sci. 2021 Jun 26. pii: 10.1007/s10620-021-07124.
    PubMed     Abstract available

  80. FRENETTE CT, Levy C, Saab S
    Hepatic Encephalopathy-Related Hospitalizations in Cirrhosis: Transition of Care and Closing the Revolving Door.
    Dig Dis Sci. 2021 Jun 24. pii: 10.1007/s10620-021-07075.
    PubMed     Abstract available

  81. HA NB, Cho SJ, Mohamad Y, Kent D, et al
    Visceral Adipose Tissue Inflammation and Radiographic Visceral-to-Subcutaneous Adipose Tissue Ratio in Patients with Cirrhosis.
    Dig Dis Sci. 2021 Jun 16. pii: 10.1007/s10620-021-07099.
    PubMed     Abstract available

  82. DAHIYA M, Eboreime E, Hyde A, Rahman S, et al
    International Classification of Diseases Codes are Useful in Identifying Cirrhosis in Administrative Databases.
    Dig Dis Sci. 2021 Jun 6. pii: 10.1007/s10620-021-07076.
    PubMed     Abstract available

  83. ZOU B, Yeo YH, Cheung R, Ingelsson E, et al
    Fatty Liver Index and Development of Cardiovascular Disease: Findings from the UK Biobank.
    Dig Dis Sci. 2021;66:2092-2100.
    PubMed     Abstract available

  84. SHARMA A, Keshava SN, Eapen A, Elias E, et al
    An Update on the Management of Budd-Chiari Syndrome.
    Dig Dis Sci. 2021;66:1780-1790.
    PubMed     Abstract available

    May 2021
  85. PENG X, Tian A, Li J, Mao Y, et al
    Diagnostic Value of FibroTouch and Non-invasive Fibrosis Indexes in Hepatic Fibrosis with Different Aetiologies.
    Dig Dis Sci. 2021 May 31. pii: 10.1007/s10620-021-07049.
    PubMed     Abstract available

  86. CACCAMO G, Franze MS, Saffioti F, Pitrone C, et al
    Cirrhotic Patients with Bacterial Infection and Negative Cultures Have a More Advanced Disease and an Increased Short-Term Mortality Rate.
    Dig Dis Sci. 2021 May 26. pii: 10.1007/s10620-021-07047.
    PubMed     Abstract available

  87. PINYOPORNPANISH K, Al-Yaman W, Dasarathy S, Romero-Marrero C, et al
    Hepatocellular Carcinoma in Patients Without Cirrhosis: The Fibrosis Stage Distribution, Characteristics and Survival.
    Dig Dis Sci. 2021 May 23. pii: 10.1007/s10620-021-07048.
    PubMed     Abstract available

  88. LI X, Lv J, Hou L, Guo X, et al
    Circ_0001955 Acts as a miR-646 Sponge to Promote the Proliferation, Metastasis and Angiogenesis of Hepatocellular Carcinoma.
    Dig Dis Sci. 2021 May 22. pii: 10.1007/s10620-021-07053.
    PubMed     Abstract available

  89. SERPER M
    Monitoring for Ascites in Cirrhosis Using Patient-Generated Health Data: No Longer a Remote Possibility.
    Dig Dis Sci. 2021 May 18. pii: 10.1007/s10620-021-07020.

  90. YU B, Zhou S, Liang H, Ye Q, et al
    Development and Validation of a Novel Circulating miRNA-Based Diagnostic Score for Early Detection of Hepatocellular Carcinoma.
    Dig Dis Sci. 2021 May 12. pii: 10.1007/s10620-021-07031.
    PubMed     Abstract available

  91. ARTEEL GE, Singhvi A, Feldman R, Althouse AD, et al
    Coexistent Alcohol-Related Liver Disease and Alcohol-Related Pancreatitis: Analysis of a Large Heath Care System Cohort.
    Dig Dis Sci. 2021 May 7. pii: 10.1007/s10620-021-07010.
    PubMed     Abstract available

  92. BLOOM PP, Ventoso M, Tapper E, Ha J, et al
    A Telemonitoring Intervention for Cirrhotic Ascites Management Is Cost-Saving.
    Dig Dis Sci. 2021 May 6. pii: 10.1007/s10620-021-07013.
    PubMed     Abstract available

  93. TO C, Liu L, Satoskar RS, Thuluvath PJ, et al
    Diabetic Hepatosclerosis in a Woman with Maturity-Onset Diabetes of the Young Type 3.
    Dig Dis Sci. 2021 May 3. pii: 10.1007/s10620-021-07005.

  94. RICH NE, Parvathaneni A, Sen A, Odewole M, et al
    High Neutrophil-Lymphocyte Ratio and Delta Neutrophil-Lymphocyte Ratio Are Associated with Increased Mortality in Patients with Hepatocellular Cancer.
    Dig Dis Sci. 2021 May 3. pii: 10.1007/s10620-021-07001.
    PubMed     Abstract available

  95. HASHIMOTO R, Lee DP, Samarasena JB, Chandan VS, et al
    Comparison of Two Specialized Histology Needles for Endoscopic Ultrasound (EUS)-Guided Liver Biopsy: A Pilot Study.
    Dig Dis Sci. 2021;66:1700-1706.
    PubMed     Abstract available

    April 2021
  96. SCHEWE J, Makeschin MC, Khandoga A, Zhang J, et al
    To Protect Fatty Livers from Ischemia Reperfusion Injury: Role of Ischemic Postconditioning.
    Dig Dis Sci. 2021;66:1349-1359.
    PubMed     Abstract available

  97. TROWELL J, Alukal J, Zhang T, Liu L, et al
    How Good Are Controlled Attenuation Parameter Scores from Fibroscan to Assess Steatosis, NASH, and Fibrosis?
    Dig Dis Sci. 2021;66:1297-1305.
    PubMed     Abstract available

  98. SINGAL AK, Ahmed Z, Axley P, Arora S, et al
    Hospitalizations for Acute on Chronic Liver Failure at Academic Compared to Non-academic Centers Have Higher Mortality.
    Dig Dis Sci. 2021;66:1306-1314.
    PubMed     Abstract available

    March 2021
  99. LIN RX, Zhan GF, Wu JC, Fang H, et al
    LncRNA SNHG14 Sponges miR-206 to Affect Proliferation, Apoptosis, and Metastasis of Hepatocellular Carcinoma Cells by Regulating SOX9.
    Dig Dis Sci. 2021 Mar 29. pii: 10.1007/s10620-021-06920.
    PubMed     Abstract available

  100. MAHMUD N, Asrani SK, Reese PP, Kaplan DE, et al
    Race Adjustment in eGFR Equations Does Not Improve Estimation of Acute Kidney Injury Events in Patients with Cirrhosis.
    Dig Dis Sci. 2021 Mar 24. pii: 10.1007/s10620-021-06943.
    PubMed     Abstract available

  101. LIN K, Huang Q, Zeng J, Ding Z, et al
    Clinical Significance of Alpha-Fetoprotein in Alpha-Fetoprotein Negative Hepatocellular Carcinoma Underwent Curative Resection.
    Dig Dis Sci. 2021 Mar 16. pii: 10.1007/s10620-020-06797.
    PubMed     Abstract available

  102. PERISETTI A, Goyal H
    Successful Distancing: Telemedicine in Gastroenterology and Hepatology During the COVID-19 Pandemic.
    Dig Dis Sci. 2021 Mar 3. pii: 10.1007/s10620-021-06874.
    PubMed     Abstract available

    February 2021
  103. MIRAGLIA R, Maruzzelli L, Luca A
    Transjugular Intrahepatic Portosystemic Shunt: A Single-Centre Mid-term Experience Using the Viatorr Controlled-Expansion Stent.
    Dig Dis Sci. 2021 Feb 27. pii: 10.1007/s10620-021-06867.

  104. WANG X, Luo X, Yang L
    Risk Factors for Hepatic Encephalopathy After Transjugular Intrahepatic Portosystemic Shunt: Beyond Stent Diameter.
    Dig Dis Sci. 2021 Feb 26. pii: 10.1007/s10620-021-06868.

  105. KANG N, Chung JW, Jang ES, Jeong SH, et al
    Computed Tomography-Measured Liver Volume Predicts the Risk of Hepatocellular Carcinoma Development in Chronic Hepatitis C Patients.
    Dig Dis Sci. 2021 Feb 25. pii: 10.1007/s10620-020-06762.
    PubMed     Abstract available

  106. XU YP, Dong ZN, Zhou YQ, Zhao YJ, et al
    Role of eIF3C Overexpression in Predicting Prognosis of Intrahepatic Cholangiocarcinoma.
    Dig Dis Sci. 2021 Feb 12. pii: 10.1007/s10620-021-06878.
    PubMed     Abstract available

  107. CHEN YC, Hsu CW, Jeng WJ, Lin CY, et al
    Advanced Liver Fibrosis Is Associated with Necroinflammatory Grade but Not Hepatic Steatosis in Chronic Hepatitis B Patients.
    Dig Dis Sci. 2021 Feb 10. pii: 10.1007/s10620-020-06761.
    PubMed     Abstract available

  108. BIE C, Chen Y, Tang H, Li Q, et al
    Insulin-Like Growth Factor 1 Receptor Drives Hepatocellular Carcinoma Growth and Invasion by Activating Stat3-Midkine-Stat3 Loop.
    Dig Dis Sci. 2021 Feb 9. pii: 10.1007/s10620-021-06862.
    PubMed     Abstract available

  109. STERLING RK, King WC, Khalili M, Kleiner DE, et al
    Performance of Serum-Based Scores for Identification of Mild Hepatic Steatosis in HBV Mono-infected and HBV-HIV Co-infected Adults.
    Dig Dis Sci. 2021 Feb 8. pii: 10.1007/s10620-021-06860.
    PubMed     Abstract available

  110. ZHANG D, Zhang Y, Zhang X, Zhai H, et al
    Circ_0091579 Serves as a Tumor-Promoting Factor in Hepatocellular Carcinoma Through miR-1225-5p/PLCB1 Axis.
    Dig Dis Sci. 2021 Feb 8. pii: 10.1007/s10620-021-06861.
    PubMed     Abstract available

  111. NAM JY, Lee YB, Lee JH, Yu SJ, et al
    A Prognostic Prediction Model of Transarterial Radioembolization in Hepatocellular Carcinoma: SNAP-HCC.
    Dig Dis Sci. 2021 Feb 4. pii: 10.1007/s10620-021-06843.
    PubMed     Abstract available

  112. ZHOU SN, Pan WT, Pan MX, Luo QY, et al
    Comparison of Immune Microenvironment Between Colon and Liver Metastatic Tissue in Colon Cancer Patients with Liver Metastasis.
    Dig Dis Sci. 2021;66:474-482.
    PubMed     Abstract available

  113. PATIDAR KR, Davis BC, Slaven JE, Ghabril MS, et al
    Admission Factor V Predicts Transplant-Free Survival in Acute Liver Failure.
    Dig Dis Sci. 2021;66:619-627.
    PubMed     Abstract available

    January 2021
  114. WU M, Jiang L
    Hydroxysteroid 17-Beta Dehydrogenase 6 Is a Prognostic Biomarker and Correlates with Immune Infiltrates in Hepatocellular Carcinoma.
    Dig Dis Sci. 2021 Jan 26. pii: 10.1007/s10620-021-06832.
    PubMed     Abstract available

  115. LI J, Bao S, Wang L, Wang R, et al
    CircZKSCAN1 Suppresses Hepatocellular Carcinoma Tumorigenesis by Regulating miR-873-5p/Downregulation of Deleted in Liver Cancer 1.
    Dig Dis Sci. 2021 Jan 13. pii: 10.1007/s10620-020-06789.
    PubMed     Abstract available

  116. ZHAO L, Ma N, Liu G, Mao N, et al
    Lidocaine Inhibits Hepatocellular Carcinoma Development by Modulating circ_ITCH/miR-421/CPEB3 Axis.
    Dig Dis Sci. 2021 Jan 12. pii: 10.1007/s10620-020-06787.
    PubMed     Abstract available

  117. XU R, Yin S, Zheng M, Pei X, et al
    Circular RNA circZFR Promotes Hepatocellular Carcinoma Progression by Regulating miR-375/HMGA2 Axis.
    Dig Dis Sci. 2021 Jan 12. pii: 10.1007/s10620-020-06805.
    PubMed     Abstract available

  118. TONTHAT A, Bui D, Romero M, Lo E, et al
    A Case of Benign Hepatic Cyst with Supra-elevated Cyst Fluid Tumor Markers.
    Dig Dis Sci. 2021 Jan 6. pii: 10.1007/s10620-020-06727.

  119. OU H, Liu Q, Lin J, He W, et al
    Pseudogene Annexin A2 Pseudogene 1 Contributes to Hepatocellular Carcinoma Progression by Modulating Its Parental Gene ANXA2 via miRNA-376a-3p.
    Dig Dis Sci. 2021 Jan 4. pii: 10.1007/s10620-020-06734.
    PubMed     Abstract available

  120. MACHADO P, Gupta I, Gummadi S, Stanczak M, et al
    Hepatic Vein Contrast-Enhanced Ultrasound Subharmonic Imaging Signal as a Screening Test for Portal Hypertension.
    Dig Dis Sci. 2021 Jan 4. pii: 10.1007/s10620-020-06790.
    PubMed     Abstract available

  121. BALDIN C, Piedade J, Guimaraes L, Victor L, et al
    CLIF-C AD Score Predicts Development of Acute Decompensations and Survival in Hospitalized Cirrhotic Patients.
    Dig Dis Sci. 2021 Jan 3. pii: 10.1007/s10620-020-06791.
    PubMed     Abstract available

  122. HUANG Y, Chu P, Bao G
    Silencing of Long Non-coding RNA TTN-AS1 Inhibits Hepatocellular Carcinoma Progression by the MicroRNA-134/ITGB1 Axis.
    Dig Dis Sci. 2021 Jan 2. pii: 10.1007/s10620-020-06737.
    PubMed     Abstract available

  123. HSU CY, Parikh ND, Huo TI, Tapper EB, et al
    Comparison of Seven Noninvasive Models for Predicting Decompensation and Hospitalization in Patients with Cirrhosis.
    Dig Dis Sci. 2021 Jan 2. pii: 10.1007/s10620-020-06763.
    PubMed     Abstract available

  124. CAVAZZA A, McPhail MJ
    Absolutely FABulous? FABP-1 in Non-acetaminophen-related Acute Liver Failure.
    Dig Dis Sci. 2021;66:10-11.

  125. ABBASS A, Khalid S, Farooq U, Rakov N, et al
    If DILI Is Suspected, Don't Dally.
    Dig Dis Sci. 2021;66:52-55.

  126. PATEL HK, Saxena R, Rush N, Patel SK, et al
    A Comparative Study of 22G versus 19G Needles for EUS-Guided Biopsies for Parenchymal Liver Disease: Are Thinner Needles Better?
    Dig Dis Sci. 2021;66:238-246.
    PubMed     Abstract available

  127. KARVELLAS CJ, Speiser JL, Tremblay M, Lee WM, et al
    Elevated Serum Liver-Type Fatty Acid Binding Protein Levels in Non-acetaminophen Acute Liver Failure Patients with Organ Dysfunction.
    Dig Dis Sci. 2021;66:273-283.
    PubMed     Abstract available

  128. KIM D, Yoo ER, Li AA, Tighe SP, et al
    Trends in Hospitalizations for Clostridioides difficile Infection in End-Stage Liver Disease, 2005-2014.
    Dig Dis Sci. 2021;66:296-307.
    PubMed     Abstract available

    December 2020
  129. BERGQUIST JR, Li AY, Chang EM, Scott GD, et al
    Nearing the Summit: Associating Liver Partitioning and Portal Ligation for Staged Hepatectomy (ALPPS) in Progressive Carcinoid Disease.
    Dig Dis Sci. 2020;65:3482-3485.

  130. LI Q, Rempel JD, Ball TB, Aukema H, et al
    Plasma Oxylipins Levels in Nonalcoholic Fatty Liver Disease.
    Dig Dis Sci. 2020;65:3605-3613.
    PubMed     Abstract available

    November 2020
  131. KLOSTER ML, Ren A, Shah KY, Alqadi MM, et al
    High Incidence of Hepatic Encephalopathy After Viatorr Controlled Expansion Transjugular Intrahepatic Portosystemic Shunt Creation.
    Dig Dis Sci. 2020 Nov 24. pii: 10.1007/s10620-020-06716.
    PubMed     Abstract available

  132. O'LEARY JG, Rajender Reddy K, Tandon P, Biggins SW, et al
    Increased Risk of ACLF and Inpatient Mortality in Hospitalized Patients with Cirrhosis and Hepatic Hydrothorax.
    Dig Dis Sci. 2020 Nov 13. pii: 10.1007/s10620-020-06677.
    PubMed     Abstract available

  133. NAYMAGON L, Tremblay D, Zubizarreta N, Moshier E, et al
    Safety, Efficacy, and Long-Term Outcomes of Anticoagulation in Cirrhotic Portal Vein Thrombosis.
    Dig Dis Sci. 2020 Nov 5. pii: 10.1007/s10620-020-06695.
    PubMed     Abstract available

  134. BERGQUIST JR, Li AY, Javadi CS, Chima RS, et al
    Too Big to Fail: Successful Resection of a Large Hepatocellular Carcinoma with Portal Tumor Thrombus.
    Dig Dis Sci. 2020 Nov 3. pii: 10.1007/s10620-020-06682.

  135. ABY ES, Pham NV, Yum JJ, Dong TS, et al
    Frailty Does Not Impact Caregiver Burden in Patients with Cirrhosis.
    Dig Dis Sci. 2020 Nov 2. pii: 10.1007/s10620-020-06687.
    PubMed     Abstract available

  136. GREWAL J, Benhammou J, Patel PV, Saab S, et al
    Casting a Wider NET: An Unusual Cause of Acute Liver Failure in a Pregnant Patient.
    Dig Dis Sci. 2020;65:3102-3105.
    PubMed     Abstract available

  137. STINE JG, Xu D, Schmitz K, Sciamanna C, et al
    Exercise Attenuates Ribosomal Protein Six Phosphorylation in Fatty Liver Disease.
    Dig Dis Sci. 2020;65:3238-3243.
    PubMed     Abstract available

  138. SINGH A, Amin H, Garg R, Gupta M, et al
    Increased Prevalence of Obesity and Metabolic Syndrome in Patients with Alcoholic Fatty Liver Disease.
    Dig Dis Sci. 2020;65:3341-3349.
    PubMed     Abstract available

  139. CHEN HW, Ferrando A, White MG, Dennis RA, et al
    Home-Based Physical Activity and Diet Intervention to Improve Physical Function in Advanced Liver Disease: A Randomized Pilot Trial.
    Dig Dis Sci. 2020;65:3350-3359.
    PubMed     Abstract available

  140. ZHANG C, Wu Y, Yuan S, Dou X, et al
    Characteristics of Drug-Induced Liver Injury in Northeast China: Disease Spectrum and Drug Types.
    Dig Dis Sci. 2020;65:3360-3368.
    PubMed     Abstract available

    October 2020
  141. WANG B, Zhao K, Hu W, Ding Y, et al
    Protective Mechanism of MIF Inhibitor ISO-1 on Intrahepatic Bile Duct Cells in Rats with Severe Acute Pancreatitis.
    Dig Dis Sci. 2020 Oct 29. pii: 10.1007/s10620-020-06674.
    PubMed     Abstract available

  142. CLARKE K, Bilal M, Sanchez-Luna SA, Dalessio S, et al
    Impact of COVID-19 Pandemic on Training: Global Perceptions of Gastroenterology and Hepatology Fellows in the USA.
    Dig Dis Sci. 2020 Oct 19. pii: 10.1007/s10620-020-06655.
    PubMed     Abstract available

  143. JI C, Hong X, Lan B, Lin Y, et al
    Circ_0091581 Promotes the Progression of Hepatocellular Carcinoma Through Targeting miR-591/FOSL2 Axis.
    Dig Dis Sci. 2020 Oct 11. pii: 10.1007/s10620-020-06641.
    PubMed     Abstract available

  144. MUNOZ AE, Pollarsky F, Marino M, Cartier M, et al
    Safety of Chronic Simvastatin Treatment in Patients with Decompensated Cirrhosis: Many Adverse Events but No Liver Injury.
    Dig Dis Sci. 2020 Oct 9. pii: 10.1007/s10620-020-06630.
    PubMed     Abstract available

  145. ATHYROS VG, Katsiki N, Mikhailidis DP
    NAFLD and Statins.
    Dig Dis Sci. 2020;65:3052-3053.

  146. ZHANG Z, Yao W, Yuan D, Huang F, et al
    Effects of Connexin 32-Mediated Lung Inflammation Resolution During Liver Ischemia Reperfusion.
    Dig Dis Sci. 2020;65:2914-2924.
    PubMed     Abstract available

    September 2020
  147. NATARAJAN Y, Tansel A, Patel P, Emelogu IK, et al
    Correction to: Incidence of Hepatocellular Carcinoma in Primary Biliary Cholangitis: A Systematic Review and Meta-Analysis.
    Dig Dis Sci. 2020 Sep 29. pii: 10.1007/s10620-020-06619.
    PubMed     Abstract available

  148. CHEN VL, Hawa F, Berinstein JA, Reddy CA, et al
    Hepatic Steatosis Is Associated with Increased Disease Severity and Liver Injury in Coronavirus Disease-19.
    Dig Dis Sci. 2020 Sep 27. pii: 10.1007/s10620-020-06618.
    PubMed     Abstract available

  149. XIAO F, Gao M, Yang J, He L, et al
    FAM172A Deletion May Enhance Hepatic Steatosis by Promoting ER Stress.
    Dig Dis Sci. 2020 Sep 18. pii: 10.1007/s10620-020-06601.
    PubMed     Abstract available

  150. TRIEU H, Patel A, Wells C, Saab S, et al
    Disparities in Mortality and Health Care Utilization for 460,851 Hospitalized Patients with Cirrhosis and Hepatic Encephalopathy.
    Dig Dis Sci. 2020 Sep 14. pii: 10.1007/s10620-020-06582.
    PubMed     Abstract available

  151. RITACCIO G, Stoleru G, Abutaleb A, Cross RK, et al
    Nonalcoholic Fatty Liver Disease Is Common in IBD Patients However Progression to Hepatic Fibrosis by Noninvasive Markers Is Rare.
    Dig Dis Sci. 2020 Sep 7. pii: 10.1007/s10620-020-06588.
    PubMed     Abstract available

  152. SIMONS-LINARES CR, Abushamma S, Romero-Marrero C, Bhatt A, et al
    Clinical Outcomes of Acute Pancreatitis in Patients with Cirrhosis According to Liver Disease Severity Scores.
    Dig Dis Sci. 2020 Sep 6. pii: 10.1007/s10620-020-06575.
    PubMed     Abstract available

  153. SHAW J, Patidar KR, Reuter B, Hajezifar N, et al
    Focused Education Increases Hepatocellular Cancer Screening in Patients with Cirrhosis Regardless of Functional Health Literacy.
    Dig Dis Sci. 2020 Sep 5. pii: 10.1007/s10620-020-06583.
    PubMed     Abstract available

  154. PATEL A, Asch S, Antonio AL, Kanwal F, et al
    Measuring the Quality of Palliative Care for Patients with End-Stage Liver Disease.
    Dig Dis Sci. 2020;65:2562-2570.
    PubMed     Abstract available

  155. SHALIMAR, Sharma S, Gamanagatti SR, Chauhan A, et al
    Acute-on-Chronic Liver Failure in Budd-Chiari Syndrome: Profile and Predictors of Outcome.
    Dig Dis Sci. 2020;65:2719-2729.
    PubMed     Abstract available

  156. AYYAGARI S, Tan MC, Liu Y, El-Serag HB, et al
    Use of Acid-Suppressant Medications After Diagnosis Increases Mortality in a Subset of Gastrointestinal Cancer Patients.
    Dig Dis Sci. 2020;65:2691-2699.
    PubMed     Abstract available

    August 2020
  157. DENG LX, Mehta N
    Does Hepatocellular Carcinoma Surveillance Increase Survival in At-Risk Populations? Patient Selection, Biomarkers, and Barriers.
    Dig Dis Sci. 2020 Aug 29. pii: 10.1007/s10620-020-06550.
    PubMed     Abstract available

  158. HYUN HK, Cho EJ, Park SY, Hong YM, et al
    Direct-Acting Antivirals Improve Treatment Outcomes in Patients with Hepatitis C Virus-Related Hepatocellular Carcinoma Treated with Transarterial Chemoembolization: A Nationwide, Multi-center, Retrospective Cohort Study.
    Dig Dis Sci. 2020 Aug 28. pii: 10.1007/s10620-020-06533.
    PubMed     Abstract available

  159. PHAW NA, Dyson JK, Mells G, Jones D, et al
    Understanding Fatigue in Primary Biliary Cholangitis.
    Dig Dis Sci. 2020 Aug 26. pii: 10.1007/s10620-020-06502.
    PubMed     Abstract available

  160. REICHERT MC, Massmann A, Schulz A, Buecker A, et al
    Volume-Function Analysis (LiMAx Test) in Patients with HCC and Cirrhosis Undergoing TACE-A Feasibility Study.
    Dig Dis Sci. 2020 Aug 20. pii: 10.1007/s10620-020-06535.
    PubMed     Abstract available

  161. PALERMO A, Gerussi A, Mulinacci G, Invernizzi P, et al
    Identifying Racial Disparities in Primary Biliary Cholangitis Patients: A Step Toward Achieving Equitable Outcomes Among All.
    Dig Dis Sci. 2020 Aug 13. pii: 10.1007/s10620-020-06528.

  162. BALAKRISHNAN M, Seth A, Cortes-Santiago N, Jain S, et al
    External Validation of Four Point-of-Care Noninvasive Scores for Predicting Advanced Hepatic Fibrosis in a Predominantly Hispanic NAFLD Population.
    Dig Dis Sci. 2020 Aug 5. pii: 10.1007/s10620-020-06501.
    PubMed     Abstract available

  163. GRUTTADAURIA S, Pagano D, di Francesco F, Foglio A, et al
    Adult to Adult Living Donor Liver Transplantation in Recipients with Low MELD: A Strategy Intended to Overcome Donor Shortage.
    Dig Dis Sci. 2020 Aug 5. pii: 10.1007/s10620-020-06522.
    PubMed     Abstract available

  164. NATARAJAN Y, Tansel A, Patel P, Emologu K, et al
    Incidence of Hepatocellular Carcinoma in Primary Biliary Cholangitis: A Systematic Review and Meta-Analysis.
    Dig Dis Sci. 2020 Aug 2. pii: 10.1007/s10620-020-06498.
    PubMed     Abstract available

  165. PALETI S, Li Y, Okwara C, McCarthy D, et al
    Liver Abscess: A Wolf in Sheep's Clothing.
    Dig Dis Sci. 2020;65:2221-2224.

    July 2020
  166. BLOOM PP, Pasricha TS, Andersson KL, Pratt DS, et al
    Hepatology Consultants Often Disagree on Etiology of Abnormal Liver Biochemistries in COVID-19 but Agree on Management.
    Dig Dis Sci. 2020 Jul 29. pii: 10.1007/s10620-020-06495.
    PubMed     Abstract available

  167. CAO Y, Tao Q, Kao X, Zhu X, et al
    Hsa-circRNA-103809 Promotes Hepatocellular Carcinoma Development via MicroRNA-1270/PLAG1 Like Zinc Finger 2 Axis.
    Dig Dis Sci. 2020 Jul 18. pii: 10.1007/s10620-020-06416.
    PubMed     Abstract available

  168. JIANG L, Chu H, Gao B, Lang S, et al
    Transcriptomic Profiling Identifies Novel Hepatic and Intestinal Genes Following Chronic Plus Binge Ethanol Feeding in Mice.
    Dig Dis Sci. 2020 Jul 15. pii: 10.1007/s10620-020-06461.
    PubMed     Abstract available

  169. LE L, Kullar R, Saleh HM, Saab S, et al
    Preferred Noninvasive Testing for Nonalcoholic Steatohepatitis.
    Dig Dis Sci. 2020 Jul 15. pii: 10.1007/s10620-020-06382.
    PubMed     Abstract available

  170. XIE X, Dou CY, Zhou Y, Zhou Q, et al
    MicroRNA-503 Targets Mothers Against Decapentaplegic Homolog 7 Enhancing Hepatic Stellate Cell Activation and Hepatic Fibrosis.
    Dig Dis Sci. 2020 Jul 9. pii: 10.1007/s10620-020-06460.
    PubMed     Abstract available

  171. KOTWAL V, Mbachi C, Wang Y, Attar B, et al
    A Novel Score to Predict Esophageal Varices in Patients with Compensated Advanced Chronic Liver Disease.
    Dig Dis Sci. 2020 Jul 9. pii: 10.1007/s10620-020-06456.
    PubMed     Abstract available

  172. AMJAD W, Alukal J, Zhang T, Maheshwari A, et al
    Two-Dose Hepatitis B Vaccine (Heplisav-B) Results in Better Seroconversion Than Three-Dose Vaccine (Engerix-B) in Chronic Liver Disease.
    Dig Dis Sci. 2020 Jul 2. pii: 10.1007/s10620-020-06437.
    PubMed     Abstract available

  173. MALLEPALLY N, Bilal M, Hernandez-Barco YG, Simons M, et al
    The New Virtual Reality: How COVID-19 Will Affect the Gastroenterology and Hepatology Fellowship Match.
    Dig Dis Sci. 2020 Jul 1. pii: 10.1007/s10620-020-06432.

  174. MORNINGSTAR JE, Syn WK, Litwin SE
    The Emerging Epidemic of Nonalcoholic Fatty Liver Disease and Cardiovascular Risk: True, True, and Related?
    Dig Dis Sci. 2020;65:1885-1887.

  175. SHRESTHA MP, Senussi N, Volpicelli N, McCarthy D, et al
    Tangled Up in Red Cells: A Large Liver Mass with Intravascular Hemolysis.
    Dig Dis Sci. 2020;65:1960-1963.

  176. LABENZ C, Huber Y, Michel M, Nagel M, et al
    Impact of NAFLD on the Incidence of Cardiovascular Diseases in a Primary Care Population in Germany.
    Dig Dis Sci. 2020;65:2112-2119.
    PubMed     Abstract available

    June 2020
  177. YUE W, Liu Y, Jiang W, Huang J, et al
    Prealbumin and D-dimer as Prognostic Indicators for Rebleeding in Patients with Nonvariceal Upper Gastrointestinal Bleeding.
    Dig Dis Sci. 2020 Jun 24. pii: 10.1007/s10620-020-06420.
    PubMed     Abstract available

  178. LOUISSAINT J, Foster C, Harding-Theobald E, Lok AS, et al
    Social Support Does Not Modify the Risk of Readmission for Patients with Decompensated Cirrhosis.
    Dig Dis Sci. 2020 Jun 23. pii: 10.1007/s10620-020-06421.
    PubMed     Abstract available

  179. GOTO T, Selzner M
    Low-Pressure Tactic: A Novel Intrahepatic Shunt Improves Outcomes in Experimental Small-for-Size Syndrome.
    Dig Dis Sci. 2020 Jun 18. pii: 10.1007/s10620-020-06385.

  180. KEGASAWA T, Sakamori R, Maesaka K, Yamada R, et al
    Lower Serum Sodium Levels Are Associated with the Therapeutic Effect of Sorafenib on Hepatocellular Carcinoma.
    Dig Dis Sci. 2020 Jun 17. pii: 10.1007/s10620-020-06380.
    PubMed     Abstract available

  181. HO SY, Hsu CY, Liu PH, Lee RC, et al
    Albumin-Bilirubin (ALBI) Grade-Based Nomogram for Patients with Hepatocellular Carcinoma Undergoing Transarterial Chemoembolization.
    Dig Dis Sci. 2020 Jun 16. pii: 10.1007/s10620-020-06384.
    PubMed     Abstract available

  182. DANFORD CJ, Lee JY, Strohbehn IA, Corey KE, et al
    Development of an Algorithm to Identify Cases of Nonalcoholic Steatohepatitis Cirrhosis in the Electronic Health Record.
    Dig Dis Sci. 2020 Jun 13. pii: 10.1007/s10620-020-06388.
    PubMed     Abstract available

  183. LONG MD, Raffals L, Williams R
    Program Directors' Perspectives of Gastroenterology and Hepatology Fellowship Application.
    Dig Dis Sci. 2020 Jun 13. pii: 10.1007/s10620-020-06378.

  184. ADEJUMO AC, Akhtar DH, Dennis BB, Cholankeril G, et al
    Gender and Racial Differences in Hospitalizations for Primary Biliary Cholangitis in the USA.
    Dig Dis Sci. 2020 Jun 13. pii: 10.1007/s10620-020-06402.
    PubMed     Abstract available

  185. BARAKAT MT, Josephs S, Gugig R
    Return to Native Drainage: Duodenal Biliary Fistula Formation Following Pediatric Hepatobiliary Surgery with Roux-en-Y Reconstruction.
    Dig Dis Sci. 2020 Jun 12. pii: 10.1007/s10620-020-06372.

  186. SHIN JW, Jeong J, Jung SW, Lee SB, et al
    Comparable Incidence of Hepatocellular Carcinoma in Chronic Hepatitis B Patients Treated with Entecavir or Tenofovir.
    Dig Dis Sci. 2020 Jun 10. pii: 10.1007/s10620-020-06375.
    PubMed     Abstract available

  187. TERBAH R, Gow P, Sinclair M, Testro A, et al
    Terlipressin for Type 1 Hepatorenal Syndrome.
    Dig Dis Sci. 2020 Jun 8. pii: 10.1007/s10620-020-06370.

  188. WANG CW, Lebsack A, Sudore RL, Lai JC, et al
    Low Rates of Advance Care Planning (ACP) Discussions Despite Readiness to Engage in ACP Among Liver Transplant Candidates.
    Dig Dis Sci. 2020 Jun 4. pii: 10.1007/s10620-020-06369.
    PubMed     Abstract available

  189. LONARDO A, Targher G
    Cardiovascular Risk in NAFLD: An Intimate Relationship?
    Dig Dis Sci. 2020;65:1593-1595.

  190. SHAO C, Ye J, Li F, Lin Y, et al
    Early Predictors of Cardiovascular Disease Risk in Nonalcoholic Fatty Liver Disease: Non-obese Versus Obese Patients.
    Dig Dis Sci. 2020;65:1850-1860.
    PubMed     Abstract available

    May 2020
  191. KHOKHAR MA, O'Beirne J
    Transjugular Intrahepatic Portosystemic Shunts for Hepatorenal Syndrome: TIPping the Scales in Whose Favor?
    Dig Dis Sci. 2020 May 29. pii: 10.1007/s10620-020-06351.

  192. SHROFF H, Rinella ME
    Thanks to CLD for Small Favors: Reduced CVD Risk in Patients Awaiting Liver Transplantation.
    Dig Dis Sci. 2020 May 29. pii: 10.1007/s10620-020-06322.

  193. LUI FH, Ma P, Helmy M, Hu KQ, et al
    Ultrasonographic (US) Two-Dimensional Measurement of Spleen Is Superior to Traditional Length Measurement Alone in Diagnosing Cirrhosis.
    Dig Dis Sci. 2020 May 23. pii: 10.1007/s10620-020-06332.
    PubMed     Abstract available

  194. CHAHAL D, Yoshida EM, Arbour L, Wallach JP, et al
    Post-partum Primary Biliary Cholangitis Preceded by Intrahepatic Cholestasis of Pregnancy in Three First Nation Patients.
    Dig Dis Sci. 2020 May 22. pii: 10.1007/s10620-020-06333.

  195. NAGAOKA K, Ogawa K, Ji C, Cao KY, et al
    Targeting Aspartate Beta-Hydroxylase with the Small Molecule Inhibitor MO-I-1182 Suppresses Cholangiocarcinoma Metastasis.
    Dig Dis Sci. 2020 May 22. pii: 10.1007/s10620-020-06330.
    PubMed     Abstract available

  196. FERRARESE A, Burra P, Senzolo M
    A Commentary on the Interplay Between Severity of Liver Disease and Bacterial Infection in Hospitalized Patients with Cirrhosis.
    Dig Dis Sci. 2020 May 8. pii: 10.1007/s10620-020-06278.

  197. FAHAD H, Sarmini MT, Modaresi-Esfeh J
    Does Obesity Affect Outcomes of Transjugular Intrahepatic Portosystemic Shunt Placement?
    Dig Dis Sci. 2020 May 6. pii: 10.1007/s10620-020-06276.

  198. CHEN X, Liu C, Ruan L
    G-Protein-Coupled Receptors 120 Agonist III Improves Hepatic Inflammation and ER Stress in Steatohepatitis.
    Dig Dis Sci. 2020 May 5. pii: 10.1007/s10620-020-06280.
    PubMed     Abstract available

  199. IZZY M, Shingina A
    Functional Status and Liver Disease Phenotype: Frailty, Thy Presence Is Ominous.
    Dig Dis Sci. 2020;65:1296-1298.

  200. MUKTHINUTHALAPATI VVPK, Attar BM, Parra-Rodriguez L, Cabrera NL, et al
    Risk Factors, Management, and Outcomes of Pyogenic Liver Abscess in a US Safety Net Hospital.
    Dig Dis Sci. 2020;65:1529-1538.
    PubMed     Abstract available

    April 2020
  201. ZHANG G, Ma J, Xiong J, Huang X, et al
    Upregulation of Excision Repair Cross-Complementation Group 6-Like (ERCC6L) Promotes Tumor Growth in Hepatocellular Carcinoma.
    Dig Dis Sci. 2020 Apr 29. pii: 10.1007/s10620-020-06277.
    PubMed     Abstract available

  202. LIU GM, Zeng HD, Zhang CY, Xu JW, et al
    Identification of METTL3 as an Adverse Prognostic Biomarker in Hepatocellular Carcinoma.
    Dig Dis Sci. 2020 Apr 24. pii: 10.1007/s10620-020-06260.
    PubMed     Abstract available

  203. ACHARYA C, White MB, Fagan A, Sterling RK, et al
    Liver Transplant Is Associated with Sustained Improvement in Tandem Gait and Risk of Falls.
    Dig Dis Sci. 2020 Apr 22. pii: 10.1007/s10620-020-06261.
    PubMed     Abstract available

  204. EL-SERAG HB, Sardell R, Thrift AP, Kanwal F, et al
    Texas Has the Highest Hepatocellular Carcinoma Incidence Rates in the USA.
    Dig Dis Sci. 2020 Apr 17. pii: 10.1007/s10620-020-06231.
    PubMed     Abstract available

  205. BLOOM PP
    A Call to Action: Novel Ways that Hepatologists Can Contribute to Patient Care During the COVID-19 Pandemic.
    Dig Dis Sci. 2020 Apr 13. pii: 10.1007/s10620-020-06251.

  206. TESTINO G
    Transjugular Intrahepatic Porto Systemic Shunt for Hepatorenal Syndrome in Alcoholic Patients.
    Dig Dis Sci. 2020 Apr 13. pii: 10.1007/s10620-020-06243.

  207. MOCTEZUMA-VELAZQUEZ C, Montano-Loza AJ, Meza-Junco J, Burak K, et al
    Selective Internal Radiation Therapy for Hepatocellular Carcinoma Across the Barcelona Clinic Liver Cancer Stages.
    Dig Dis Sci. 2020 Apr 12. pii: 10.1007/s10620-020-06245.
    PubMed     Abstract available

  208. SUN RF, Zhao CY, Chen S, Yu W, et al
    Androgen Receptor Stimulates Hexokinase 2 and Induces Glycolysis by PKA/CREB Signaling in Hepatocellular Carcinoma.
    Dig Dis Sci. 2020 Apr 9. pii: 10.1007/s10620-020-06229.
    PubMed     Abstract available

  209. TURKSEVEN S, Bolognesi M, Di Pascoli M
    Contribution of Splenic Resistance Arteries to Splanchnic Blood Overflow in Cirrhosis.
    Dig Dis Sci. 2020 Apr 2. pii: 10.1007/s10620-020-06233.
    PubMed     Abstract available

  210. TIEN PC, Duarte M, Roque A, Price J, et al
    MRE and ELF in Liver Fibrosis Assessment: Are Two Better Than One?
    Dig Dis Sci. 2020;65:928-930.

  211. SHERIF ZA
    Unmasking a Stealth Killer: The Need for Increased Awareness of NASH.
    Dig Dis Sci. 2020;65:987-989.

  212. KAPLAN DE
    A Matter of TACEte: Plain Vanilla or Combination?
    Dig Dis Sci. 2020;65:934-936.

  213. DIPAOLA F, Trout AT, Walther AE, Gupta A, et al
    Congenital Portosystemic Shunts in Children: Associations, Complications, and Outcomes.
    Dig Dis Sci. 2020;65:1239-1251.
    PubMed     Abstract available

  214. SINGH A, Dhaliwal AS, Singh S, Kumar A, et al
    Awareness of Nonalcoholic Fatty Liver Disease Is Increasing but Remains Very Low in a Representative US Cohort.
    Dig Dis Sci. 2020;65:978-986.
    PubMed     Abstract available

    March 2020
  215. ZORI A, Villanueva F, Hatamleh D, Ismael M, et al
    Favorable Survival with Non-curative Treatments for Patients with Early-Stage Hepatocellular Carcinoma After Liver Transplant Denial.
    Dig Dis Sci. 2020 Mar 26. pii: 10.1007/s10620-020-06201.
    PubMed     Abstract available

  216. WANG C, Luo J, Chen Z, Ye M, et al
    MiR-375 Impairs the Invasive Capabilities of Hepatoma Cells by Targeting HIF1alpha Under Hypoxia.
    Dig Dis Sci. 2020 Mar 25. pii: 10.1007/s10620-020-06202.
    PubMed     Abstract available

  217. SHAMA S, Liu W
    Omega-3 Fatty Acids and Gut Microbiota: A Reciprocal Interaction in Nonalcoholic Fatty Liver Disease.
    Dig Dis Sci. 2020;65:906-910.
    PubMed     Abstract available

  218. LECHNER S, Yee M, Limketkai BN, Pham EA, et al
    Fecal Microbiota Transplantation for Chronic Liver Diseases: Current Understanding and Future Direction.
    Dig Dis Sci. 2020;65:897-905.
    PubMed     Abstract available

    February 2020
    Liver Transplantation for Alcoholic Liver Disease: What Is the Risk and Consequence of Relapse?
    Dig Dis Sci. 2020 Feb 14. pii: 10.1007/s10620-020-06127.
    PubMed     Abstract available

    January 2020
  220. LU J, Wang H, Zhang R, Wan Z, et al
    Effects of Photoperiod on Acetaminophen-Induced Hepatotoxicity in Mice.
    Dig Dis Sci. 2020;65:178-188.
    PubMed     Abstract available

  221. MILES DA, Levi CS, Uhanova J, Cuvelier S, et al
    Pocket-Sized Versus Conventional Ultrasound for Detecting Fatty Infiltration of the Liver.
    Dig Dis Sci. 2020;65:82-85.
    PubMed     Abstract available

    December 2019
  222. KAPS L, Grambihler A, Yemane B, Nagel M, et al
    Symptom Burden and Treatment Response in Patients with Primary Biliary Cholangitis (PBC).
    Dig Dis Sci. 2019 Dec 18. pii: 10.1007/s10620-019-06009.
    PubMed     Abstract available

    November 2019
  223. DEUTSCH-LINK S, Weinrieb RM, Jones LS, Solga SF, et al
    Prior Relapse, Ongoing Alcohol Consumption, and Failure to Engage in Treatment Predict Alcohol Relapse After Liver Transplantation.
    Dig Dis Sci. 2019 Nov 9. pii: 10.1007/s10620-019-05937.
    PubMed     Abstract available

  224. SIMMONS OL, Meinzer C, Rule J, Lee WM, et al
    Liver Transplantation for Acetaminophen-Induced Acute Liver Failure: Role of Psychiatric Comorbidity in Listing Decisions and Outcomes.
    Dig Dis Sci. 2019 Nov 2. pii: 10.1007/s10620-019-05901.
    PubMed     Abstract available

    October 2019
  225. MCCABE P, Galoosian A, Wong RJ
    Patients with Alcoholic Liver Disease Have Worse Functional Status at Time of Liver Transplant Registration and Greater Waitlist and Post-transplant Mortality Which Is Compounded by Older Age.
    Dig Dis Sci. 2019 Oct 22. pii: 10.1007/s10620-019-05891.
    PubMed     Abstract available

    September 2019
  226. GALOOSIAN A, Hanlon C, Tana M, Cheung R, et al
    Race/Ethnicity and Insurance-Specific Disparities in In-Hospital Mortality Among Adults with Primary Biliary Cholangitis: Analysis of 2007-2014 National Inpatient Sample.
    Dig Dis Sci. 2019 Sep 5. pii: 10.1007/s10620-019-05809.
    PubMed     Abstract available

    August 2019
  227. HAO YL, Bian ZL, Ju LL, Liu Y, et al
    RANK/RANKL Acts as a Protective Factor by Targeting Cholangiocytes in Primary Biliary Cholangitis.
    Dig Dis Sci. 2019 Aug 3. pii: 10.1007/s10620-019-05758.
    PubMed     Abstract available

    July 2019
  228. KUZNIETSOVA HM, Dziubenko NV, Lynchak OV, Herheliuk TS, et al
    Effects of Pristine C60 Fullerenes on Liver and Pancreas in alpha-Naphthylisothiocyanate-Induced Cholangitis.
    Dig Dis Sci. 2019 Jul 16. pii: 10.1007/s10620-019-05730.
    PubMed     Abstract available

    May 2019
  229. TU W, Gong J, Tian D, Wang Z, et al
    Hepatitis B Virus X Protein Induces SATB1 Expression Through Activation of ERK and p38MAPK Pathways to Suppress Anoikis.
    Dig Dis Sci. 2019 May 30. pii: 10.1007/s10620-019-05681.
    PubMed     Abstract available

    April 2019
  230. KALANI A, Phan J, Taefi A, Deshmukh M, et al
    Necrotizing Pancreatitis: Common and Uncommon Sequelae and Solutions.
    Dig Dis Sci. 2019 Apr 27. pii: 10.1007/s10620-019-05634.

Thank you for your interest in scientific medicine.

AMEDEO Liver Diseases is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.